Category: Medications - Page 2

How to Use Patient Assistance Programs When No Generic Medication Exists

Keith Ashcroft
|
January 10
|
13

When no generic drug exists, patient assistance programs can cut costs from thousands to zero. Learn how to apply, avoid common traps like accumulator adjustments, and find help for brand-name medications.

Patent Exclusivity vs Market Exclusivity: What’s the Real Difference for Drug Prices?

Beata Staszkow
|
January 8
|
14

Patent exclusivity and market exclusivity are two different legal tools that delay generic drugs. One protects inventions; the other protects clinical data. Both affect drug prices-and patients pay the difference.

Immunosuppressive Combinations: Generic Options for Transplant Care

Keith Ashcroft
|
January 7
|
13

Generic immunosuppressants like tacrolimus and mycophenolate offer the same protection as brand-name drugs at 80% lower cost. Learn how they work, their risks, and why they’re now the standard for transplant care.

How to Use Pharmacy Apps to Track Potential Drug Interactions

Keith Ashcroft
|
January 5
|
12

Learn how to use pharmacy apps to spot dangerous drug interactions before they happen. Discover the best apps for patients and pros, how they work, and how to avoid costly mistakes with prescriptions, supplements, and OTC meds.

Muscle Aches from Statins: What Really Causes It and What to Do

Keith Ashcroft
|
January 4
|
15

Muscle aches from statins are common but often overestimated. Learn what's really causing the pain, when to worry, and how to stay protected without quitting your heart medication.

Questions to Ask Your Pharmacist About Prescription Medications

Beata Staszkow
|
January 3
|
9

Learn the essential questions to ask your pharmacist about prescription medications to avoid errors, manage side effects, save money, and stay safe. Get practical advice backed by research and real-world examples.

Annual Boxed Warnings Summary: What Changed and Why It Matters

Keith Ashcroft
|
January 1
|
0

The 2025 FDA boxed warnings update reveals new, specific safety alerts for drugs like GLP-1 agonists and immunomodulators. These changes mean clearer guidance for doctors and safer use for patients.

Annual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown

Beata Staszkow
|
December 31
|
8

Year-by-year breakdown of how much the U.S. saves thanks to FDA-approved generic drugs, from $7.1 billion in 2019 to $445 billion in 2023 total savings. Learn how generics cut costs, who benefits, and why savings vary.

Migraine Combination Medications: Generic Options and How They Work

Beata Staszkow
|
December 28
|
9

Discover how generic migraine combination medications like sumatriptan/naproxen and acetaminophen/aspirin/caffeine offer better relief at a fraction of the cost. Learn which combos work best and how to use them safely.

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Keith Ashcroft
|
December 25
|
8

The FDA doesn't rate biosimilars like generics - it rigorously evaluates them for molecular similarity, safety, and efficacy. Learn how the approval process works, why only 17 are interchangeable, and how they're changing patient access to biologics.